Business / Finance

RSS

Meda reaches agreement with Valeant to terminate joint ventures

Meda has reached an agreement with Valeant to terminate the companies' joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates have been established.

7 Apr 2014

Exact Sciences announces pricing of underwritten public offering of common stock

Exact Sciences Corp. today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public.

4 Apr 2014

Bjond raises $3.25M in Series A financing to accelerate its flagship software

Today Bjond, Inc. announced that it closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures.

4 Apr 2014

Bio-Techne makes $10M equity investment in CyVek

Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met.

4 Apr 2014

Transgenomic to provide genetic testing services for Raptor’s clinical trial

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing services for Raptor's clinical trial (RP103-MITO-001) evaluating RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.

4 Apr 2014

Seward increases production capacity for Stomacher blender bags in the UK

Seward Ltd., manufacturer of the world leading range of original Stomacher paddle blenders and accessories used in sample preparation for microbiological analysis, has increased production capacity for Stomacher blender bags with additional manufacturing in the UK.

4 Apr 2014

United Recovery Systems acquires Array Services Group

United Recovery Systems, a portfolio company of Audax Private Equity, announced it has completed the acquisition of Array Services Group. Array, headquartered in Sartell, MN, is a leading regionally-focused provider of revenue cycle management, receivables management, and call center services to hospitals, healthcare systems, retail businesses, and financial service institutions.

4 Apr 2014

ZirMed acquires TransEngen's payment processing and patient engagement solutions

ZirMed, a leading health information connectivity and management solutions company, today announced that it has acquired the payment processing, patient eligibility and patient estimation business solutions owned by TransEngen Inc., a company located in Shelton, CT.

4 Apr 2014

Aesynt completes acquisition of Health Robotics

Aesynt™, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced it has completed the acquisition of Health Robotics, the leading global supplier of automated technology for intravenous (IV) medication preparation, compounding and dispensing.

3 Apr 2014

CTMM, TI Pharma team up to create new public-private healthcare innovation

Leading Dutch technology institutes CTMM (Center for Translational Molecular Medicine) and TI Pharma have joined forces, in a merger that addresses the growing interdependence of medicines and medical technology.

3 Apr 2014

Accele Venture Partners co-led $4.1M Series A private equity financing of Otologic Pharmaceutics

Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc., announced today that it has co-led a $4.1 million Series A private equity financing of Otologic Pharmaceutics, Inc. (OPI), a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders.

3 Apr 2014

Corium International prices initial public offering of common stock

Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today the pricing of its initial public offering of 6,500,000 shares of common stock at a price to the public of $8.00 per share.

3 Apr 2014

Walgreens' March sales up 4.5% to $6.43 billion

Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.

3 Apr 2014

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round to further advance development of EB-1020 SR, a non-stimulant, for the treatment of all subtypes of adult ADHD (attention deficit hyperactivity disorder).

3 Apr 2014

Foundation Medicine, Clovis Oncology expand collaboration to develop novel companion diagnostic test

Foundation Medicine, Inc. and Clovis Oncology, Inc. today announced the expansion of their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval (PMA) companion diagnostic test.

3 Apr 2014

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.

3 Apr 2014

Biomet's consolidated net sales increase 6.6% to $822.5 million

Biomet, Inc. announced today financial results for its third quarter ended February 28, 2014.

3 Apr 2014

Affygility’s occupational exposure limit monograph is now available for delta-9-tetrahydrocannabinol

Affygility Solutions is pleased to announce that its occupational exposure limit monograph is now available for delta-9-tetrahydrocannabinol, the principal psychoactive ingredient in marijuana.

3 Apr 2014

Cardinal Health agrees to acquire AccessClosure for $320 million

Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.

3 Apr 2014

Actavis opens new regional headquarters in Singapore

Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.

3 Apr 2014

Business / Finance

Meda reaches agreement with Valeant to terminate joint ventures

Exact Sciences announces pricing of underwritten public offering of common stock

Bjond raises $3.25M in Series A financing to accelerate its flagship software

Bio-Techne makes $10M equity investment in CyVek

Transgenomic to provide genetic testing services for Raptor’s clinical trial

Seward increases production capacity for Stomacher blender bags in the UK

United Recovery Systems acquires Array Services Group

ZirMed acquires TransEngen's payment processing and patient engagement solutions

Aesynt completes acquisition of Health Robotics

CTMM, TI Pharma team up to create new public-private healthcare innovation

Accele Venture Partners co-led $4.1M Series A private equity financing of Otologic Pharmaceutics

Corium International prices initial public offering of common stock

Walgreens' March sales up 4.5% to $6.43 billion

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Foundation Medicine, Clovis Oncology expand collaboration to develop novel companion diagnostic test

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Biomet's consolidated net sales increase 6.6% to $822.5 million

Affygility’s occupational exposure limit monograph is now available for delta-9-tetrahydrocannabinol

Cardinal Health agrees to acquire AccessClosure for $320 million

Actavis opens new regional headquarters in Singapore

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News